144 related articles for article (PubMed ID: 19184289)
1. Standardization for mass production of allogeneic cultured dermal substitute by measuring the amount of VEGF, bFGF, HGF, TGF-beta, and IL-8.
Hashimoto A; Kuroyanagi Y
J Artif Organs; 2008; 11(4):225-31. PubMed ID: 19184289
[TBL] [Abstract][Full Text] [Related]
2. Potential of a cryopreserved cultured dermal substitute composed of hyaluronic acid and collagen to release angiogenic cytokine.
Sawa M; Kuroyanagi Y
J Biomater Sci Polym Ed; 2013; 24(2):224-38. PubMed ID: 23565599
[TBL] [Abstract][Full Text] [Related]
3. A study of cytokines released from fibroblasts in cultured dermal substitute.
Kubo K; Kuroyanagi Y
Artif Organs; 2005 Oct; 29(10):845-9. PubMed ID: 16185348
[TBL] [Abstract][Full Text] [Related]
4. Establishment of banking system for allogeneic cultured dermal substitute.
Kuroyanagi Y; Kubo K; Matsui H; Kim HJ; Numari S; Mabuchi Y; Kagawa S
Artif Organs; 2004 Jan; 28(1):13-21. PubMed ID: 14720283
[TBL] [Abstract][Full Text] [Related]
5. Effect of EGF and bFGF on fibroblast proliferation and angiogenic cytokine production from cultured dermal substitutes.
Yu A; Matsuda Y; Takeda A; Uchinuma E; Kuroyanagi Y
J Biomater Sci Polym Ed; 2012; 23(10):1315-24. PubMed ID: 21722419
[TBL] [Abstract][Full Text] [Related]
6. Wound dressing composed of hyaluronic acid and collagen containing EGF or bFGF: comparative culture study.
Yu A; Niiyama H; Kondo S; Yamamoto A; Suzuki R; Kuroyanagi Y
J Biomater Sci Polym Ed; 2013; 24(8):1015-26. PubMed ID: 23647255
[TBL] [Abstract][Full Text] [Related]
7. The possibility of long-term cryopreservation of cultured dermal substitute.
Kubo K; Kuroyanagi Y
Artif Organs; 2005 Oct; 29(10):800-5. PubMed ID: 16185341
[TBL] [Abstract][Full Text] [Related]
8. Development of a cultured dermal substitute composed of a spongy matrix of hyaluronic acid and atelo-collagen combined with fibroblasts: fundamental evaluation.
Kubo K; Kuroyanagi Y
J Biomater Sci Polym Ed; 2003; 14(7):625-41. PubMed ID: 12903732
[TBL] [Abstract][Full Text] [Related]
9. Development of cultured dermal substitute composed of hyaluronic acid and collagen spongy sheet containing fibroblasts and epidermal growth factor.
Kuroyanagi M; Yamamoto A; Shimizu N; Ishihara E; Ohno H; Takeda A; Kuroyanagi Y
J Biomater Sci Polym Ed; 2014; 25(11):1133-43. PubMed ID: 24890602
[TBL] [Abstract][Full Text] [Related]
10. Effects of vascular endothelial growth factor released from cultured dermal substitute on proliferation of vascular endothelial cells in vitro.
Kubo K; Kuroyanagi Y
J Artif Organs; 2003; 6(4):267-72. PubMed ID: 14691669
[TBL] [Abstract][Full Text] [Related]
11. Development of a cultured dermal substitute composed of a spongy matrix of hyaluronic acid and atelo-collagen combined with fibroblasts: cryopreservation.
Kubo K; Kuroyanagi Y
Artif Organs; 2004 Feb; 28(2):182-8. PubMed ID: 14961958
[TBL] [Abstract][Full Text] [Related]
12. Hepatocyte growth factor stimulated angiogenesis without inflammation: differential actions between hepatocyte growth factor, vascular endothelial growth factor and basic fibroblast growth factor.
Kaga T; Kawano H; Sakaguchi M; Nakazawa T; Taniyama Y; Morishita R
Vascul Pharmacol; 2012 Aug; 57(1):3-9. PubMed ID: 22361334
[TBL] [Abstract][Full Text] [Related]
13. Comparative evaluation of re-epithelialization promoted by fresh or cryopreserved cultured dermal substitute.
Yamada N; Uchinuma E; Matsumoto Y; Kuroyanagi Y
J Artif Organs; 2008; 11(4):221-4. PubMed ID: 19184288
[TBL] [Abstract][Full Text] [Related]
14. Extracellular matrix/stromal vascular fraction gel conditioned medium accelerates wound healing in a murine model.
Deng C; He Y; Feng J; Dong Z; Yao Y; Mok H; Lin M; Feng L
Wound Repair Regen; 2017 Nov; 25(6):923-932. PubMed ID: 29240284
[TBL] [Abstract][Full Text] [Related]
15. Allogeneic cultured dermal substitute composed of spongy collagen containing fibroblasts: evaluation in animal test.
Tanaka M; Nakakita N; Kuroyanagi Y
J Biomater Sci Polym Ed; 1999; 10(4):433-53. PubMed ID: 10227466
[TBL] [Abstract][Full Text] [Related]
16. Potential of wound dressing composed of hyaluronic acid containing epidermal growth factor to enhance cytokine production by fibroblasts.
Yamamoto A; Shimizu N; Kuroyanagi Y
J Artif Organs; 2013 Dec; 16(4):489-94. PubMed ID: 24013475
[TBL] [Abstract][Full Text] [Related]
17. Development of novel wound dressing composed of hyaluronic acid and collagen sponge containing epidermal growth factor and vitamin C derivative.
Niiyama H; Kuroyanagi Y
J Artif Organs; 2014 Mar; 17(1):81-7. PubMed ID: 24292853
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-17 enhances bFGF-, HGF- and VEGF-induced growth of vascular endothelial cells.
Takahashi H; Numasaki M; Lotze MT; Sasaki H
Immunol Lett; 2005 May; 98(2):189-93. PubMed ID: 15860217
[TBL] [Abstract][Full Text] [Related]
19. Tissue-engineered product: allogeneic cultured dermal substitute composed of spongy collagen with fibroblasts.
Kuroyanagi Y; Yamada N; Yamashita R; Uchinuma E
Artif Organs; 2001 Mar; 25(3):180-6. PubMed ID: 11284884
[TBL] [Abstract][Full Text] [Related]
20. Basic Fibroblast Growth Factor Influences Epidermal Homeostasis of Living Skin Equivalents through Affecting Fibroblast Phenotypes and Functions.
Yang L; Zhang D; Wu H; Xie S; Zhang M; Zhang B; Tang S
Skin Pharmacol Physiol; 2018; 31(5):229-237. PubMed ID: 29847822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
